ChaitaliNangiaMD
Oncology • Newport Beach, CAAssistant Professor, Medicine, University of California, Irvine, School of Medicine
Dr. Nangia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hoag Drive
Newport Beach, CA 92663Phone+1 949-764-5347Fax+1 949-557-0221
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 1999 - 2002
Lady Hardinge Medical CollegeClass of 1998
Certifications & Licensure
CA State Medical License 2011 - 2025
MI State Medical License 2002 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-09-14 - 36 citationsComprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment OptionsSungeun Kim, Kyle Fedorchak, Madappa N. Kundranda, Yazmin Odia, Chaitali Singh Nangia
The Oncologist. 2017-07-01 - 17 citationsThe Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.Umut Disel, Russell Madison, Kumar Abhishek, Jon Chung, Sally E. Trabucco
The Oncologist. 2020-01-01
Journal Articles
- Single-Cell Transcriptomes Reveal the Mechanism for a Breast Cancer Prognostic Gene PanelChaitali S Nangia, Lilibeth Torno, William G Loudon, Mustafa H Kabeer, Ashley S Plant, Shengwen Calvin Li, Oncotarget
Press Mentions
NantKwest and ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy with Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at SABCSDecember 16th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
